Global Human Plasma Derivative Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Human Plasma Derivative market size was valued at US$ 36350 million in 2024 and is forecast to a readjusted size of USD 59300 million by 2031 with a CAGR of 7.3% during review period.
Human Plasma Derivative: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.
Driver of the Human Plasma Derivative Market:
One of the main drivers of the Human Plasma Derivative market is the increasing prevalence of rare and chronic diseases, such as hemophilia, primary immunodeficiency disorders, and autoimmune diseases. These conditions require ongoing treatment with Human Plasma Derivative like clotting factors, immunoglobulins, and albumin. The growing awareness and diagnosis rates of such diseases, along with advancements in plasma collection and fractionation technologies, have contributed to a higher demand for these therapies. Additionally, increasing investments in healthcare infrastructure and government support in emerging markets are fueling market growth.
Challenge of the Human Plasma Derivative Market:
A key challenge in this market is the complex and costly process of plasma collection and product manufacturing. Human Plasma Derivative require large volumes of plasma, which can only be obtained through human donors. The stringent regulations surrounding plasma collection, donor screening, and testing to ensure safety make the process time-consuming and expensive. Furthermore, any disruption in plasma supply chains, such as those caused by geopolitical issues or pandemics, can lead to shortages and impact treatment availability.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Human Plasma Derivative includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Human Plasma Derivative market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Human Plasma Derivative.
This report is a detailed and comprehensive analysis for global Human Plasma Derivative market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Plasma Derivative market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human Plasma Derivative market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human Plasma Derivative market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human Plasma Derivative market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Plasma Derivative
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Plasma Derivative market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Human Plasma Derivative market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
Market segment by Application
- Hospital
- Retail Pharmacy
- Other
Market segment by players, this report covers
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Plasma Derivative product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Plasma Derivative, with revenue, gross margin, and global market share of Human Plasma Derivative from 2020 to 2025.
Chapter 3, the Human Plasma Derivative competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Plasma Derivative market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Plasma Derivative.
Chapter 13, to describe Human Plasma Derivative research findings and conclusion.
Human Plasma Derivative: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.
Driver of the Human Plasma Derivative Market:
One of the main drivers of the Human Plasma Derivative market is the increasing prevalence of rare and chronic diseases, such as hemophilia, primary immunodeficiency disorders, and autoimmune diseases. These conditions require ongoing treatment with Human Plasma Derivative like clotting factors, immunoglobulins, and albumin. The growing awareness and diagnosis rates of such diseases, along with advancements in plasma collection and fractionation technologies, have contributed to a higher demand for these therapies. Additionally, increasing investments in healthcare infrastructure and government support in emerging markets are fueling market growth.
Challenge of the Human Plasma Derivative Market:
A key challenge in this market is the complex and costly process of plasma collection and product manufacturing. Human Plasma Derivative require large volumes of plasma, which can only be obtained through human donors. The stringent regulations surrounding plasma collection, donor screening, and testing to ensure safety make the process time-consuming and expensive. Furthermore, any disruption in plasma supply chains, such as those caused by geopolitical issues or pandemics, can lead to shortages and impact treatment availability.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Human Plasma Derivative includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Human Plasma Derivative market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Human Plasma Derivative.
This report is a detailed and comprehensive analysis for global Human Plasma Derivative market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Plasma Derivative market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human Plasma Derivative market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human Plasma Derivative market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human Plasma Derivative market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Plasma Derivative
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Plasma Derivative market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Human Plasma Derivative market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
Market segment by Application
- Hospital
- Retail Pharmacy
- Other
Market segment by players, this report covers
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Plasma Derivative product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Plasma Derivative, with revenue, gross margin, and global market share of Human Plasma Derivative from 2020 to 2025.
Chapter 3, the Human Plasma Derivative competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Plasma Derivative market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Plasma Derivative.
Chapter 13, to describe Human Plasma Derivative research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Plasma Derivative by Type
1.3.1 Overview: Global Human Plasma Derivative Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Human Plasma Derivative Consumption Value Market Share by Type in 2024
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Other
1.4 Global Human Plasma Derivative Market by Application
1.4.1 Overview: Global Human Plasma Derivative Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Human Plasma Derivative Market Size & Forecast
1.6 Global Human Plasma Derivative Market Size and Forecast by Region
1.6.1 Global Human Plasma Derivative Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Human Plasma Derivative Market Size by Region, (2020-2031)
1.6.3 North America Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.4 Europe Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.6 South America Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Human Plasma Derivative Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Human Plasma Derivative Product and Solutions
2.1.4 Takeda Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Plasma Derivative Product and Solutions
2.2.4 CSL Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Human Plasma Derivative Product and Solutions
2.3.4 Grifols Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Human Plasma Derivative Product and Solutions
2.4.4 Octapharma Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Human Plasma Derivative Product and Solutions
2.5.4 Kedrion Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Human Plasma Derivative Product and Solutions
2.6.4 LFB Group Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Human Plasma Derivative Product and Solutions
2.7.4 Biotest Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Human Plasma Derivative Product and Solutions
2.8.4 BPL Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Human Plasma Derivative Product and Solutions
2.9.4 RAAS Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Human Plasma Derivative Product and Solutions
2.10.4 CBPO Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Human Plasma Derivative Product and Solutions
2.11.4 Hualan Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Human Plasma Derivative Product and Solutions
2.12.4 Tiantan Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Human Plasma Derivative Product and Solutions
2.13.4 Shuanglin Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Human Plasma Derivative Product and Solutions
2.14.4 Boya Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Human Plasma Derivative Product and Solutions
2.15.4 Yuanda Shuyang Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Human Plasma Derivative Product and Solutions
2.16.4 Weiguang Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Human Plasma Derivative Product and Solutions
2.17.4 Nanyue Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Human Plasma Derivative Product and Solutions
2.18.4 KM Biologics Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 KM Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Human Plasma Derivative Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Human Plasma Derivative by Company Revenue
3.2.2 Top 3 Human Plasma Derivative Players Market Share in 2024
3.2.3 Top 6 Human Plasma Derivative Players Market Share in 2024
3.3 Human Plasma Derivative Market: Overall Company Footprint Analysis
3.3.1 Human Plasma Derivative Market: Region Footprint
3.3.2 Human Plasma Derivative Market: Company Product Type Footprint
3.3.3 Human Plasma Derivative Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Human Plasma Derivative Consumption Value and Market Share by Type (2020-2025)
4.2 Global Human Plasma Derivative Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Human Plasma Derivative Consumption Value Market Share by Application (2020-2025)
5.2 Global Human Plasma Derivative Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Human Plasma Derivative Consumption Value by Type (2020-2031)
6.2 North America Human Plasma Derivative Market Size by Application (2020-2031)
6.3 North America Human Plasma Derivative Market Size by Country
6.3.1 North America Human Plasma Derivative Consumption Value by Country (2020-2031)
6.3.2 United States Human Plasma Derivative Market Size and Forecast (2020-2031)
6.3.3 Canada Human Plasma Derivative Market Size and Forecast (2020-2031)
6.3.4 Mexico Human Plasma Derivative Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Human Plasma Derivative Consumption Value by Type (2020-2031)
7.2 Europe Human Plasma Derivative Consumption Value by Application (2020-2031)
7.3 Europe Human Plasma Derivative Market Size by Country
7.3.1 Europe Human Plasma Derivative Consumption Value by Country (2020-2031)
7.3.2 Germany Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.3 France Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.5 Russia Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.6 Italy Human Plasma Derivative Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Human Plasma Derivative Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Human Plasma Derivative Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Human Plasma Derivative Market Size by Region
8.3.1 Asia-Pacific Human Plasma Derivative Consumption Value by Region (2020-2031)
8.3.2 China Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.3 Japan Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.4 South Korea Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.5 India Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.7 Australia Human Plasma Derivative Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Human Plasma Derivative Consumption Value by Type (2020-2031)
9.2 South America Human Plasma Derivative Consumption Value by Application (2020-2031)
9.3 South America Human Plasma Derivative Market Size by Country
9.3.1 South America Human Plasma Derivative Consumption Value by Country (2020-2031)
9.3.2 Brazil Human Plasma Derivative Market Size and Forecast (2020-2031)
9.3.3 Argentina Human Plasma Derivative Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Human Plasma Derivative Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Human Plasma Derivative Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Human Plasma Derivative Market Size by Country
10.3.1 Middle East & Africa Human Plasma Derivative Consumption Value by Country (2020-2031)
10.3.2 Turkey Human Plasma Derivative Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Human Plasma Derivative Market Size and Forecast (2020-2031)
10.3.4 UAE Human Plasma Derivative Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Human Plasma Derivative Market Drivers
11.2 Human Plasma Derivative Market Restraints
11.3 Human Plasma Derivative Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Human Plasma Derivative Industry Chain
12.2 Human Plasma Derivative Upstream Analysis
12.3 Human Plasma Derivative Midstream Analysis
12.4 Human Plasma Derivative Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Plasma Derivative by Type
1.3.1 Overview: Global Human Plasma Derivative Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Human Plasma Derivative Consumption Value Market Share by Type in 2024
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Other
1.4 Global Human Plasma Derivative Market by Application
1.4.1 Overview: Global Human Plasma Derivative Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Human Plasma Derivative Market Size & Forecast
1.6 Global Human Plasma Derivative Market Size and Forecast by Region
1.6.1 Global Human Plasma Derivative Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Human Plasma Derivative Market Size by Region, (2020-2031)
1.6.3 North America Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.4 Europe Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.6 South America Human Plasma Derivative Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Human Plasma Derivative Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Human Plasma Derivative Product and Solutions
2.1.4 Takeda Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Plasma Derivative Product and Solutions
2.2.4 CSL Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Human Plasma Derivative Product and Solutions
2.3.4 Grifols Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Human Plasma Derivative Product and Solutions
2.4.4 Octapharma Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Human Plasma Derivative Product and Solutions
2.5.4 Kedrion Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Human Plasma Derivative Product and Solutions
2.6.4 LFB Group Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Human Plasma Derivative Product and Solutions
2.7.4 Biotest Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Human Plasma Derivative Product and Solutions
2.8.4 BPL Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Human Plasma Derivative Product and Solutions
2.9.4 RAAS Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Human Plasma Derivative Product and Solutions
2.10.4 CBPO Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Human Plasma Derivative Product and Solutions
2.11.4 Hualan Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Human Plasma Derivative Product and Solutions
2.12.4 Tiantan Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Human Plasma Derivative Product and Solutions
2.13.4 Shuanglin Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Human Plasma Derivative Product and Solutions
2.14.4 Boya Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Human Plasma Derivative Product and Solutions
2.15.4 Yuanda Shuyang Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Human Plasma Derivative Product and Solutions
2.16.4 Weiguang Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Human Plasma Derivative Product and Solutions
2.17.4 Nanyue Bio Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Human Plasma Derivative Product and Solutions
2.18.4 KM Biologics Human Plasma Derivative Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 KM Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Human Plasma Derivative Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Human Plasma Derivative by Company Revenue
3.2.2 Top 3 Human Plasma Derivative Players Market Share in 2024
3.2.3 Top 6 Human Plasma Derivative Players Market Share in 2024
3.3 Human Plasma Derivative Market: Overall Company Footprint Analysis
3.3.1 Human Plasma Derivative Market: Region Footprint
3.3.2 Human Plasma Derivative Market: Company Product Type Footprint
3.3.3 Human Plasma Derivative Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Human Plasma Derivative Consumption Value and Market Share by Type (2020-2025)
4.2 Global Human Plasma Derivative Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Human Plasma Derivative Consumption Value Market Share by Application (2020-2025)
5.2 Global Human Plasma Derivative Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Human Plasma Derivative Consumption Value by Type (2020-2031)
6.2 North America Human Plasma Derivative Market Size by Application (2020-2031)
6.3 North America Human Plasma Derivative Market Size by Country
6.3.1 North America Human Plasma Derivative Consumption Value by Country (2020-2031)
6.3.2 United States Human Plasma Derivative Market Size and Forecast (2020-2031)
6.3.3 Canada Human Plasma Derivative Market Size and Forecast (2020-2031)
6.3.4 Mexico Human Plasma Derivative Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Human Plasma Derivative Consumption Value by Type (2020-2031)
7.2 Europe Human Plasma Derivative Consumption Value by Application (2020-2031)
7.3 Europe Human Plasma Derivative Market Size by Country
7.3.1 Europe Human Plasma Derivative Consumption Value by Country (2020-2031)
7.3.2 Germany Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.3 France Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.5 Russia Human Plasma Derivative Market Size and Forecast (2020-2031)
7.3.6 Italy Human Plasma Derivative Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Human Plasma Derivative Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Human Plasma Derivative Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Human Plasma Derivative Market Size by Region
8.3.1 Asia-Pacific Human Plasma Derivative Consumption Value by Region (2020-2031)
8.3.2 China Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.3 Japan Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.4 South Korea Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.5 India Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Human Plasma Derivative Market Size and Forecast (2020-2031)
8.3.7 Australia Human Plasma Derivative Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Human Plasma Derivative Consumption Value by Type (2020-2031)
9.2 South America Human Plasma Derivative Consumption Value by Application (2020-2031)
9.3 South America Human Plasma Derivative Market Size by Country
9.3.1 South America Human Plasma Derivative Consumption Value by Country (2020-2031)
9.3.2 Brazil Human Plasma Derivative Market Size and Forecast (2020-2031)
9.3.3 Argentina Human Plasma Derivative Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Human Plasma Derivative Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Human Plasma Derivative Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Human Plasma Derivative Market Size by Country
10.3.1 Middle East & Africa Human Plasma Derivative Consumption Value by Country (2020-2031)
10.3.2 Turkey Human Plasma Derivative Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Human Plasma Derivative Market Size and Forecast (2020-2031)
10.3.4 UAE Human Plasma Derivative Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Human Plasma Derivative Market Drivers
11.2 Human Plasma Derivative Market Restraints
11.3 Human Plasma Derivative Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Human Plasma Derivative Industry Chain
12.2 Human Plasma Derivative Upstream Analysis
12.3 Human Plasma Derivative Midstream Analysis
12.4 Human Plasma Derivative Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Plasma Derivative Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Plasma Derivative Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Human Plasma Derivative Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Human Plasma Derivative Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Human Plasma Derivative Product and Solutions
Table 8. Takeda Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Takeda Recent Developments and Future Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Human Plasma Derivative Product and Solutions
Table 13. CSL Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. CSL Recent Developments and Future Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Human Plasma Derivative Product and Solutions
Table 18. Grifols Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Octapharma Company Information, Head Office, and Major Competitors
Table 20. Octapharma Major Business
Table 21. Octapharma Human Plasma Derivative Product and Solutions
Table 22. Octapharma Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Octapharma Recent Developments and Future Plans
Table 24. Kedrion Company Information, Head Office, and Major Competitors
Table 25. Kedrion Major Business
Table 26. Kedrion Human Plasma Derivative Product and Solutions
Table 27. Kedrion Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Kedrion Recent Developments and Future Plans
Table 29. LFB Group Company Information, Head Office, and Major Competitors
Table 30. LFB Group Major Business
Table 31. LFB Group Human Plasma Derivative Product and Solutions
Table 32. LFB Group Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LFB Group Recent Developments and Future Plans
Table 34. Biotest Company Information, Head Office, and Major Competitors
Table 35. Biotest Major Business
Table 36. Biotest Human Plasma Derivative Product and Solutions
Table 37. Biotest Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Biotest Recent Developments and Future Plans
Table 39. BPL Company Information, Head Office, and Major Competitors
Table 40. BPL Major Business
Table 41. BPL Human Plasma Derivative Product and Solutions
Table 42. BPL Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. BPL Recent Developments and Future Plans
Table 44. RAAS Company Information, Head Office, and Major Competitors
Table 45. RAAS Major Business
Table 46. RAAS Human Plasma Derivative Product and Solutions
Table 47. RAAS Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. RAAS Recent Developments and Future Plans
Table 49. CBPO Company Information, Head Office, and Major Competitors
Table 50. CBPO Major Business
Table 51. CBPO Human Plasma Derivative Product and Solutions
Table 52. CBPO Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. CBPO Recent Developments and Future Plans
Table 54. Hualan Bio Company Information, Head Office, and Major Competitors
Table 55. Hualan Bio Major Business
Table 56. Hualan Bio Human Plasma Derivative Product and Solutions
Table 57. Hualan Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Hualan Bio Recent Developments and Future Plans
Table 59. Tiantan Bio Company Information, Head Office, and Major Competitors
Table 60. Tiantan Bio Major Business
Table 61. Tiantan Bio Human Plasma Derivative Product and Solutions
Table 62. Tiantan Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Tiantan Bio Recent Developments and Future Plans
Table 64. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 65. Shuanglin Bio Major Business
Table 66. Shuanglin Bio Human Plasma Derivative Product and Solutions
Table 67. Shuanglin Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Shuanglin Bio Recent Developments and Future Plans
Table 69. Boya Bio Company Information, Head Office, and Major Competitors
Table 70. Boya Bio Major Business
Table 71. Boya Bio Human Plasma Derivative Product and Solutions
Table 72. Boya Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Boya Bio Recent Developments and Future Plans
Table 74. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 75. Yuanda Shuyang Major Business
Table 76. Yuanda Shuyang Human Plasma Derivative Product and Solutions
Table 77. Yuanda Shuyang Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Yuanda Shuyang Recent Developments and Future Plans
Table 79. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 80. Weiguang Bio Major Business
Table 81. Weiguang Bio Human Plasma Derivative Product and Solutions
Table 82. Weiguang Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Weiguang Bio Recent Developments and Future Plans
Table 84. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 85. Nanyue Bio Major Business
Table 86. Nanyue Bio Human Plasma Derivative Product and Solutions
Table 87. Nanyue Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Nanyue Bio Recent Developments and Future Plans
Table 89. KM Biologics Company Information, Head Office, and Major Competitors
Table 90. KM Biologics Major Business
Table 91. KM Biologics Human Plasma Derivative Product and Solutions
Table 92. KM Biologics Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. KM Biologics Recent Developments and Future Plans
Table 94. Global Human Plasma Derivative Revenue (USD Million) by Players (2020-2025)
Table 95. Global Human Plasma Derivative Revenue Share by Players (2020-2025)
Table 96. Breakdown of Human Plasma Derivative by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Human Plasma Derivative, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 98. Head Office of Key Human Plasma Derivative Players
Table 99. Human Plasma Derivative Market: Company Product Type Footprint
Table 100. Human Plasma Derivative Market: Company Product Application Footprint
Table 101. Human Plasma Derivative New Market Entrants and Barriers to Market Entry
Table 102. Human Plasma Derivative Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Human Plasma Derivative Consumption Value (USD Million) by Type (2020-2025)
Table 104. Global Human Plasma Derivative Consumption Value Share by Type (2020-2025)
Table 105. Global Human Plasma Derivative Consumption Value Forecast by Type (2026-2031)
Table 106. Global Human Plasma Derivative Consumption Value by Application (2020-2025)
Table 107. Global Human Plasma Derivative Consumption Value Forecast by Application (2026-2031)
Table 108. North America Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 109. North America Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 110. North America Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 115. Europe Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 116. Europe Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 121. Asia-Pacific Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 122. Asia-Pacific Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Human Plasma Derivative Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Human Plasma Derivative Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 127. South America Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 128. South America Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 133. Middle East & Africa Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 134. Middle East & Africa Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Human Plasma Derivative Upstream (Raw Materials)
Table 139. Global Human Plasma Derivative Typical Customers
Table 1. Global Human Plasma Derivative Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Plasma Derivative Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Human Plasma Derivative Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Human Plasma Derivative Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Human Plasma Derivative Product and Solutions
Table 8. Takeda Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Takeda Recent Developments and Future Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Human Plasma Derivative Product and Solutions
Table 13. CSL Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. CSL Recent Developments and Future Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Human Plasma Derivative Product and Solutions
Table 18. Grifols Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Octapharma Company Information, Head Office, and Major Competitors
Table 20. Octapharma Major Business
Table 21. Octapharma Human Plasma Derivative Product and Solutions
Table 22. Octapharma Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Octapharma Recent Developments and Future Plans
Table 24. Kedrion Company Information, Head Office, and Major Competitors
Table 25. Kedrion Major Business
Table 26. Kedrion Human Plasma Derivative Product and Solutions
Table 27. Kedrion Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Kedrion Recent Developments and Future Plans
Table 29. LFB Group Company Information, Head Office, and Major Competitors
Table 30. LFB Group Major Business
Table 31. LFB Group Human Plasma Derivative Product and Solutions
Table 32. LFB Group Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LFB Group Recent Developments and Future Plans
Table 34. Biotest Company Information, Head Office, and Major Competitors
Table 35. Biotest Major Business
Table 36. Biotest Human Plasma Derivative Product and Solutions
Table 37. Biotest Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Biotest Recent Developments and Future Plans
Table 39. BPL Company Information, Head Office, and Major Competitors
Table 40. BPL Major Business
Table 41. BPL Human Plasma Derivative Product and Solutions
Table 42. BPL Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. BPL Recent Developments and Future Plans
Table 44. RAAS Company Information, Head Office, and Major Competitors
Table 45. RAAS Major Business
Table 46. RAAS Human Plasma Derivative Product and Solutions
Table 47. RAAS Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. RAAS Recent Developments and Future Plans
Table 49. CBPO Company Information, Head Office, and Major Competitors
Table 50. CBPO Major Business
Table 51. CBPO Human Plasma Derivative Product and Solutions
Table 52. CBPO Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. CBPO Recent Developments and Future Plans
Table 54. Hualan Bio Company Information, Head Office, and Major Competitors
Table 55. Hualan Bio Major Business
Table 56. Hualan Bio Human Plasma Derivative Product and Solutions
Table 57. Hualan Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Hualan Bio Recent Developments and Future Plans
Table 59. Tiantan Bio Company Information, Head Office, and Major Competitors
Table 60. Tiantan Bio Major Business
Table 61. Tiantan Bio Human Plasma Derivative Product and Solutions
Table 62. Tiantan Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Tiantan Bio Recent Developments and Future Plans
Table 64. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 65. Shuanglin Bio Major Business
Table 66. Shuanglin Bio Human Plasma Derivative Product and Solutions
Table 67. Shuanglin Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Shuanglin Bio Recent Developments and Future Plans
Table 69. Boya Bio Company Information, Head Office, and Major Competitors
Table 70. Boya Bio Major Business
Table 71. Boya Bio Human Plasma Derivative Product and Solutions
Table 72. Boya Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Boya Bio Recent Developments and Future Plans
Table 74. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 75. Yuanda Shuyang Major Business
Table 76. Yuanda Shuyang Human Plasma Derivative Product and Solutions
Table 77. Yuanda Shuyang Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Yuanda Shuyang Recent Developments and Future Plans
Table 79. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 80. Weiguang Bio Major Business
Table 81. Weiguang Bio Human Plasma Derivative Product and Solutions
Table 82. Weiguang Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Weiguang Bio Recent Developments and Future Plans
Table 84. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 85. Nanyue Bio Major Business
Table 86. Nanyue Bio Human Plasma Derivative Product and Solutions
Table 87. Nanyue Bio Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Nanyue Bio Recent Developments and Future Plans
Table 89. KM Biologics Company Information, Head Office, and Major Competitors
Table 90. KM Biologics Major Business
Table 91. KM Biologics Human Plasma Derivative Product and Solutions
Table 92. KM Biologics Human Plasma Derivative Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. KM Biologics Recent Developments and Future Plans
Table 94. Global Human Plasma Derivative Revenue (USD Million) by Players (2020-2025)
Table 95. Global Human Plasma Derivative Revenue Share by Players (2020-2025)
Table 96. Breakdown of Human Plasma Derivative by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Human Plasma Derivative, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 98. Head Office of Key Human Plasma Derivative Players
Table 99. Human Plasma Derivative Market: Company Product Type Footprint
Table 100. Human Plasma Derivative Market: Company Product Application Footprint
Table 101. Human Plasma Derivative New Market Entrants and Barriers to Market Entry
Table 102. Human Plasma Derivative Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Human Plasma Derivative Consumption Value (USD Million) by Type (2020-2025)
Table 104. Global Human Plasma Derivative Consumption Value Share by Type (2020-2025)
Table 105. Global Human Plasma Derivative Consumption Value Forecast by Type (2026-2031)
Table 106. Global Human Plasma Derivative Consumption Value by Application (2020-2025)
Table 107. Global Human Plasma Derivative Consumption Value Forecast by Application (2026-2031)
Table 108. North America Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 109. North America Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 110. North America Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 115. Europe Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 116. Europe Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 121. Asia-Pacific Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 122. Asia-Pacific Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Human Plasma Derivative Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Human Plasma Derivative Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 127. South America Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 128. South America Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Human Plasma Derivative Consumption Value by Type (2020-2025) & (USD Million)
Table 133. Middle East & Africa Human Plasma Derivative Consumption Value by Type (2026-2031) & (USD Million)
Table 134. Middle East & Africa Human Plasma Derivative Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Human Plasma Derivative Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Human Plasma Derivative Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Human Plasma Derivative Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Human Plasma Derivative Upstream (Raw Materials)
Table 139. Global Human Plasma Derivative Typical Customers
LIST OF FIGURES
Figure 1. Human Plasma Derivative Picture
Figure 2. Global Human Plasma Derivative Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Plasma Derivative Consumption Value Market Share by Type in 2024
Figure 4. Immune Globulin
Figure 5. Coagulation Factor
Figure 6. Albumin
Figure 7. Other
Figure 8. Global Human Plasma Derivative Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Human Plasma Derivative Consumption Value Market Share by Application in 2024
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Human Plasma Derivative Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Human Plasma Derivative Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Human Plasma Derivative Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Human Plasma Derivative Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Human Plasma Derivative Consumption Value Market Share by Region in 2024
Figure 18. North America Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Human Plasma Derivative Revenue Share by Players in 2024
Figure 25. Human Plasma Derivative Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Human Plasma Derivative by Player Revenue in 2024
Figure 27. Top 3 Human Plasma Derivative Players Market Share in 2024
Figure 28. Top 6 Human Plasma Derivative Players Market Share in 2024
Figure 29. Global Human Plasma Derivative Consumption Value Share by Type (2020-2025)
Figure 30. Global Human Plasma Derivative Market Share Forecast by Type (2026-2031)
Figure 31. Global Human Plasma Derivative Consumption Value Share by Application (2020-2025)
Figure 32. Global Human Plasma Derivative Market Share Forecast by Application (2026-2031)
Figure 33. North America Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 43. France Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Human Plasma Derivative Consumption Value Market Share by Region (2020-2031)
Figure 50. China Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 53. India Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 67. Human Plasma Derivative Market Drivers
Figure 68. Human Plasma Derivative Market Restraints
Figure 69. Human Plasma Derivative Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Human Plasma Derivative Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Human Plasma Derivative Picture
Figure 2. Global Human Plasma Derivative Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Plasma Derivative Consumption Value Market Share by Type in 2024
Figure 4. Immune Globulin
Figure 5. Coagulation Factor
Figure 6. Albumin
Figure 7. Other
Figure 8. Global Human Plasma Derivative Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Human Plasma Derivative Consumption Value Market Share by Application in 2024
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Human Plasma Derivative Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Human Plasma Derivative Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Human Plasma Derivative Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Human Plasma Derivative Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Human Plasma Derivative Consumption Value Market Share by Region in 2024
Figure 18. North America Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Human Plasma Derivative Revenue Share by Players in 2024
Figure 25. Human Plasma Derivative Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Human Plasma Derivative by Player Revenue in 2024
Figure 27. Top 3 Human Plasma Derivative Players Market Share in 2024
Figure 28. Top 6 Human Plasma Derivative Players Market Share in 2024
Figure 29. Global Human Plasma Derivative Consumption Value Share by Type (2020-2025)
Figure 30. Global Human Plasma Derivative Market Share Forecast by Type (2026-2031)
Figure 31. Global Human Plasma Derivative Consumption Value Share by Application (2020-2025)
Figure 32. Global Human Plasma Derivative Market Share Forecast by Application (2026-2031)
Figure 33. North America Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 43. France Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Human Plasma Derivative Consumption Value Market Share by Region (2020-2031)
Figure 50. China Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 53. India Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Human Plasma Derivative Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Human Plasma Derivative Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Human Plasma Derivative Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Human Plasma Derivative Consumption Value (2020-2031) & (USD Million)
Figure 67. Human Plasma Derivative Market Drivers
Figure 68. Human Plasma Derivative Market Restraints
Figure 69. Human Plasma Derivative Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Human Plasma Derivative Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
